IM
Last reporting period 30 Sep, 2023
Updated —
Last price
—
Market cap $B
8.726
Exchange
XNAS - Nasdaq
135 %
Last period Net income growth rate
87%
Net income growth rate has increased in 5 years
What is Net income growth rate ?
An indicator of the company's profit growth rate relative to the same periods of previous years.
See also ImmunoGen
Company Analysis
IMGN valuation, rating, competitors, insights and company profile
Eyestock Rating
IMGN financial analysis by Eyestock methodology
Valuation
IMGN valuation using historical relative method
Statements
IMGN Income Statements, Balance Sheet and Cash Flow Statements
Dividends
IMGN dividend yield and annual dividend
An indicator of the company's profit growth rate relative to the same periods of previous years.
ImmunoGen`s Net income growth rate for the period ended 2023-09-30 is 135 %
